| Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses M Letko, A Marzi, V Munster Nature microbiology 5 (4), 562-569, 2020 | 3670 | 2020 |
| Bat-borne virus diversity, spillover and emergence M Letko, SN Seifert, KJ Olival, RK Plowright, VJ Munster Nature Reviews Microbiology 18 (8), 461-471, 2020 | 498 | 2020 |
| Origin of the HIV-1 group O epidemic in western lowland gorillas M D’arc, A Ayouba, A Esteban, GH Learn, V Boué, F Liegeois, L Etienne, ... Proceedings of the National Academy of Sciences 112 (11), E1343-E1352, 2015 | 306 | 2015 |
| Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection K Rosenke, K Meade-White, M Letko, C Clancy, F Hansen, Y Liu, ... Emerging microbes & infections 9 (1), 2673-2684, 2020 | 221 | 2020 |
| Why is there low morbidity and mortality of COVID-19 in Africa? MK Njenga, J Dawa, M Nanyingi, J Gachohi, I Ngere, M Letko, CF Otieno, ... The American journal of tropical medicine and hygiene 103 (2), 564, 2020 | 206 | 2020 |
| Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol 5: 562–569 M Letko, A Marzi, V Munster | 129 | 2020 |
| Adaptive evolution of MERS-CoV to species variation in DPP4 M Letko, K Miazgowicz, R McMinn, SN Seifert, I Sola, L Enjuanes, ... Cell Reports 24 (7), 1730-1737, 2018 | 128 | 2018 |
| HIV-1 Vif adaptation to human APOBEC3H haplotypes M Ooms, B Brayton, M Letko, SM Maio, CD Pilcher, FM Hecht, JD Barbour, ... Cell host & microbe 14 (4), 411-421, 2013 | 122 | 2013 |
| Functional assessment of cell entry and receptor usage for lineage B β-coronaviruses, including 2019-nCoV M Letko, V Munster BioRxiv, 2020 | 75 | 2020 |
| The evolutionary history of ACE2 usage within the coronavirus subgenus Sarbecovirus HL Wells, M Letko, G Lasso, B Ssebide, J Nziza, DK Byarugaba, ... Virus Evolution 7 (1), veab007, 2021 | 73 | 2021 |
| Identification of the HIV-1 Vif and human APOBEC3G protein interface M Letko, T Booiman, N Kootstra, V Simon, M Ooms Cell reports 13 (9), 1789-1799, 2015 | 72 | 2015 |
| Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020; 5 (4): 562–9 M Letko, A Marzi, V Munster | 72 | |
| A single-dose ChAdOx1-vectored vaccine provides complete protection against Nipah Bangladesh and Malaysia in Syrian golden hamsters N van Doremalen, T Lambe, S Sebastian, T Bushmaker, R Fischer, ... PLoS neglected tropical diseases 13 (6), e0007462, 2019 | 67 | 2019 |
| APOBEC3G Polymorphism as a Selective Barrier to Cross-Species Transmission and Emergence of Pathogenic SIV and AIDS in a Primate Host A Krupp, KR McCarthy, M Ooms, M Letko, JS Morgan, V Simon, ... PLoS pathogens 9 (10), e1003641, 2013 | 66 | 2013 |
| Anti-spike antibodies and neutralising antibody activity in people living with HIV vaccinated with COVID-19 mRNA-1273 vaccine: a prospective single-centre cohort study A Lombardi, GM Butta, L Donnici, G Bozzi, M Oggioni, P Bono, M Matera, ... The Lancet Regional Health–Europe 13, 2022 | 58 | 2022 |
| Bactrian camels shed large quantities of Middle East respiratory syndrome coronavirus (MERS-CoV) after experimental infection DR Adney, M Letko, IK Ragan, D Scott, N van Doremalen, RA Bowen, ... Emerging microbes & infections 8 (1), 717-723, 2019 | 49 | 2019 |
| An ACE2-dependent Sarbecovirus in Russian bats is resistant to SARS-CoV-2 vaccines SN Seifert, S Bai, S Fawcett, EB Norton, KJ Zwezdaryk, J Robinson, ... PLoS Pathogens 18 (9), e1010828, 2022 | 48* | 2022 |
| Vif proteins from diverse primate lentiviral lineages use the same binding site in APOBEC3G M Letko, G Silvestri, BH Hahn, F Bibollet-Ruche, O Gokcumen, V Simon, ... Journal of virology 87 (21), 11861-11871, 2013 | 45 | 2013 |
| The resistance of human APOBEC3H to HIV-1 NL4-3 molecular clone is determined by a single amino acid in Vif M Ooms, M Letko, M Binka, V Simon PloS one 8 (2), e57744, 2013 | 42 | 2013 |
| ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challenge RJ Fischer, JN Purushotham, N van Doremalen, S Sebastian, ... npj Vaccines 6 (1), 32, 2021 | 36 | 2021 |